{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T03:04:06Z","timestamp":1772593446211,"version":"3.50.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Mathematical modeling is used to understand disease dynamics, forecast trends, and inform public health prioritization. We conducted a comparative analysis of tuberculosis (TB) epidemiology and potential intervention effects in California, using three previously developed epidemiologic models of TB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To compare the influence of various modeling methods and assumptions on epidemiologic projections of domestic latent TB infection (LTBI) control interventions in California.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We compared model results between 2005 and 2050 under a base-case scenario representing current TB services and alternative scenarios including: 1) sustained interruption of Mycobacterium tuberculosis (Mtb) transmission, 2) sustained resolution of LTBI and TB prior to entry of new residents, and 3) one-time targeted testing and treatment of LTBI among 25% of non\u2013U.S.-born individuals residing in California.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Model estimates of TB cases and deaths in California were in close agreement over the historical period but diverged for LTBI prevalence and new Mtb infections\u2014outcomes for which definitive data are unavailable. Between 2018 and 2050, models projected average annual declines of 0.58\u20131.42% in TB cases, without additional interventions. A one-time LTBI testing and treatment intervention among non\u2013U.S.-born residents was projected to produce sustained reductions in TB incidence. Models found prevalent Mtb infection and migration to be more significant drivers of future TB incidence than local transmission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>All models projected a stagnation in the decline of TB incidence, highlighting the need for additional interventions including greater access to LTBI diagnosis and treatment for non\u2013U.S.-born individuals. Differences in model results reflect gaps in historical data and uncertainty in the trends of key parameters, demonstrating the need for high-quality, up-to-date data on TB determinants and outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201907-1289oc","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T15:21:41Z","timestamp":1571412101000},"page":"356-365","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":16,"title":["Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California"],"prefix":"10.1093","volume":"201","author":[{"given":"Nicolas A.","family":"Menzies","sequence":"first","affiliation":[{"name":"Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Parriott","sequence":"additional","affiliation":[{"name":"Philip R. Lee Institute for Health Policy Studies"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sourya","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Dowdy","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Salomon","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University, Palo Alto, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.","family":"Marks","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, CDC, Atlanta, Georgia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew N.","family":"Hill","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, CDC, Atlanta, Georgia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla A.","family":"Winston","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, CDC, Atlanta, Georgia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett R.","family":"Asay","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, CDC, Atlanta, Georgia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pennan","family":"Barry","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Branch, California Department of Public Health, Richmond, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Readhead","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Branch, California Department of Public Health, Richmond, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Flood","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Branch, California Department of Public Health, Richmond, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Kahn","sequence":"additional","affiliation":[{"name":"Philip R. Lee Institute for Health Policy Studies"},{"name":"Department of Epidemiology and Biostatistics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0279-8170","authenticated-orcid":false,"given":"Priya B.","family":"Shete","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,2,1]]},"reference":[{"key":"2026030321403713000_bib1","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/ajt.15384","article-title":"Tuberculosis: United States, 2018","volume":"19","author":"Talwar","year":"2019","journal-title":"Am J Transplant"},{"key":"2026030321403713000_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15585\/mmwr.mm6511a2","article-title":"Leveling of tuberculosis incidence: United States, 2013\u20132015","volume":"65","author":"Salinas","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026030321403713000_bib3","article-title":"Reported tuberculosis in the United States, 2017","author":"U.S. CDC","year":"2018"},{"key":"2026030321403713000_bib4","doi-asserted-by":"crossref","first-page":"926","DOI":"10.5588\/ijtld.15.1001","article-title":"Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades","volume":"20","author":"Castro","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026030321403713000_bib5","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1017\/S095026881100286X","article-title":"Modelling tuberculosis trends in the USA","volume":"140","author":"Hill","year":"2012","journal-title":"Epidemiol Infect"},{"key":"2026030321403713000_bib6","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/aje\/kwy094","article-title":"Prospects for tuberculosis elimination in the United States: results of a transmission dynamic model","volume":"187","author":"Menzies","year":"2018","journal-title":"Am J Epidemiol"},{"key":"2026030321403713000_bib7","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201702-0377OC","article-title":"Comparing drivers and dynamics of tuberculosis in California, Florida, New York, and Texas","volume":"196","author":"Shrestha","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321403713000_bib8","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2468-2667(17)30119-6","article-title":"Current and future trends in tuberculosis incidence in New York City: a dynamic modelling analysis","volume":"2","author":"Fojo","year":"2017","journal-title":"Lancet Public Health"},{"key":"2026030321403713000_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3201\/eid0602.000207","article-title":"Multivariate Markovian modeling of tuberculosis: forecast for the United States","volume":"6","author":"Debanne","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"2026030321403713000_bib10","doi-asserted-by":"crossref","first-page":"e0214532","DOI":"10.1371\/journal.pone.0214532","article-title":"Outlook for tuberculosis elimination in California: an individual-based stochastic model","volume":"14","author":"Goodell","year":"2019","journal-title":"PLoS One"},{"key":"2026030321403713000_bib11","doi-asserted-by":"crossref","first-page":"e806","DOI":"10.1016\/S2214-109X(16)30199-1","article-title":"Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models","volume":"4","author":"Houben","year":"2016","journal-title":"Lancet Glob Health"},{"key":"2026030321403713000_bib12","doi-asserted-by":"crossref","first-page":"e816","DOI":"10.1016\/S2214-109X(16)30265-0","article-title":"Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models","volume":"4","author":"Menzies","year":"2016","journal-title":"Lancet Glob Health"},{"key":"2026030321403713000_bib13","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/QAD.0000000000000085","article-title":"The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models","volume":"28","author":"Pretorius","year":"2014","journal-title":"AIDS"},{"key":"2026030321403713000_bib14","doi-asserted-by":"crossref","first-page":"866","DOI":"10.5588\/ijtld.12.0573","article-title":"Data needs for evidence-based decisions: a tuberculosis modeler\u2019s \u2018wish list\u2019","volume":"17","author":"Dowdy","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026030321403713000_bib15","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1016\/S1473-3099(18)30134-8","article-title":"Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions","volume":"18","author":"s","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2026030321403713000_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.epidem.2017.06.002","article-title":"Optimally capturing latency dynamics in models of tuberculosis transmission","volume":"21","author":"Ragonnet","year":"2017","journal-title":"Epidemics"},{"key":"2026030321403713000_bib17","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/aje\/kwz147","article-title":"Impact and effectiveness of state-level tuberculosis interventions in California, Florida, New York, and Texas: a model-based analysis","volume":"188","author":"Shrestha","year":"2019","journal-title":"Am J Epidemiol"},{"key":"2026030321403713000_bib18","article-title":"2018 California tuberculosis fact sheet","author":"California Department of Public Health","year":"2019"},{"key":"2026030321403713000_bib19","first-page":"1","article-title":"The American community survey","volume":"60","author":"Mather","year":"2005","journal-title":"Popul Bull"},{"key":"2026030321403713000_bib20","doi-asserted-by":"crossref","first-page":"e0140881","DOI":"10.1371\/journal.pone.0140881","article-title":"Tuberculosis infection in the United States: prevalence estimates from the national health and nutrition examination survey, 2011\u20132012","volume":"10","author":"Miramontes","year":"2015","journal-title":"PLoS One"},{"key":"2026030321403713000_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1164\/rccm.201508-1683OC","article-title":"The prevalence of latent tuberculosis infection in the United States","volume":"194","author":"Mancuso","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321403713000_bib22","author":"U.S. CDC"},{"key":"2026030321403713000_bib23","article-title":"Multiple Cause of Death 1999\u20132015 on CDC WONDER online database, released December, 2016","author":"National Center for Health Statistics","year":"2016"},{"key":"2026030321403713000_bib24","article-title":"2016 state and city tuberculosis indicators report","author":"U.S. CDC","year":"2017"},{"key":"2026030321403713000_bib25","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"2026030321403713000_bib26","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection","volume":"60","author":"Jereb","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026030321403713000_bib27","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","author":"International Union Against Tuberculosis Committee on Prophylaxis","year":"1982","journal-title":"Bull World Health Organ"},{"key":"2026030321403713000_bib28","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","author":"Comstock","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026030321403713000_bib29","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw694","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/CDC clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026030321403713000_bib30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for latent tuberculosis infection in adults: U.S. Preventive Services Task Force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"2026030321403713000_bib31","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201702-0377OC","article-title":"Comparing drivers and dynamics of tuberculosis in California, Florida, New York, and Texas","volume":"196","author":"Shrestha","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321403713000_bib32","article-title":"Report on tuberculosis in California, 2015","author":"California Department of Public Health Tuberculosis Control Branch","year":"2016"},{"key":"2026030321403713000_bib33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/aje\/kwv121","article-title":"A field-validated approach using surveillance and genotyping data to estimate tuberculosis attributable to recent transmission in the United States","volume":"182","author":"France","year":"2015","journal-title":"Am J Epidemiol"},{"key":"2026030321403713000_bib34","doi-asserted-by":"crossref","first-page":"e0153728","DOI":"10.1371\/journal.pone.0153728","article-title":"Recent transmission of tuberculosis\u2014 United States, 2011\u20132014","volume":"11","author":"Yuen","year":"2016","journal-title":"PLoS One"},{"key":"2026030321403713000_bib35","article-title":"Tuberculosis technical instructions for panel physicians","author":"Division of Global Migration and Quarantine","year":"2018"},{"key":"2026030321403713000_bib36","first-page":"229","article-title":"Trends in tuberculosis: United States, 2013","volume":"63","author":"Alami","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026030321403713000_bib37","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0272989X12458348","article-title":"Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM modeling good research practices task force working group-6","volume":"32","author":"Briggs","year":"2012","journal-title":"Med Decis Making"},{"key":"2026030321403713000_bib38","author":"California Department of Public Health"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/201\/3\/356\/67179119\/ajrccm_201_3_356.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/201\/3\/356\/67179119\/ajrccm_201_3_356.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:40:50Z","timestamp":1772592050000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/201\/3\/356\/8496556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,2,1]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201907-1289oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2020,2,1]]},"assertion":[{"value":"2019-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}